[Artículo traducido] Inhibidores de JAK en dermatitis atópica asociados al riesgo de infecciones virales: evaluación crítica
-
Published:2023-03
Issue:3
Volume:114
Page:T277-T278
-
ISSN:0001-7310
-
Container-title:Actas Dermo-Sifiliográficas
-
language:es
-
Short-container-title:Actas Dermo-Sifiliográficas
Reference10 articles.
1. Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis;Wood;Int J Dermatol,2022
2. Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?;Shah;J Dermatol Treat,2021
3. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial;Simpson;Lancet,2020
4. Interferon-gamma: An overview of signals, mechanisms and functions;Schroder;J Leukoc Biol,2004
5. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts;Onda;J Immunol,2014